Study of Utidelone Based Neoadjuvant Treatment on Early High-risk or Locally Advanced Breast Cancer

NCT05983094 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

181

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Neoadjuvant Therapy

Interventions

DRUG: Utidelone
DRUG: Carboplatin
DRUG: Epirubicin
DRUG: Trastuzumab
DRUG: Pertuzumab

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Collaborators

[object Object]
[object Object]
[object Object]